StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Pfizer Inc.
NYSE:PFE
Sector
Location
Market Cap
USD 139.12 B
Share Price
USD 24.47
Avg Daily Volume
44,965,832
Change (1 day)
-0.45%
Change (1 year)
-17.64%
Change (YTD)
-7.76%
Pfizer Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending March 29, 2025: USD 0.00
Pfizer Inc. Common Stock Issued is USD 0.00 for the Trailing 12 Months (TTM) ending March 29, 2025. Common stock issued is cash received from issuing new shares of the company’s common stock.
-
Pfizer Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 0.00.
-
Pfizer Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending April 02, 2023 was USD 0.00.
-
Pfizer Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending April 03, 2022 was USD 0.00, a -100.00% change year over year.
-
Pfizer Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending April 04, 2021 was USD 425.00 M.
Competitors
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%
Cencora, Inc.
USD 292.87
COR
-1.51
-0.51%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.18
600276.SS
+0.14
1.80%
Takeda Pharmaceutical Company Limited
USD 29.16
4502.T
-0.53
-1.77%
Haleon plc
USD 4.81
HLN.L
-0.00
-0.08%
Daiichi Sankyo Company, Limited
USD 24.17
4568.T
+0.03
0.11%
Ucb S.A.
USD 203.26
UCB.BR
+1.51
0.75%
BeOne Medicines Ltd.
USD 294.55
ONC
+4.20
1.45%
Hansoh Pharmaceutical Group Company Limited
USD 4.59
3692.HK
+0.20
4.51%
Key Data
| Date | Common Stock Issued | Common Stock Repurchased | Free Cash Flow | Operating Cash Flow |
|---|
Competitors
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%
Cencora, Inc.
USD 292.87
COR
-1.51
-0.51%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.18
600276.SS
+0.14
1.80%
Takeda Pharmaceutical Company Limited
USD 29.16
4502.T
-0.53
-1.77%
Haleon plc
USD 4.81
HLN.L
-0.00
-0.08%
Daiichi Sankyo Company, Limited
USD 24.17
4568.T
+0.03
0.11%
Ucb S.A.
USD 203.26
UCB.BR
+1.51
0.75%
BeOne Medicines Ltd.
USD 294.55
ONC
+4.20
1.45%
Hansoh Pharmaceutical Group Company Limited
USD 4.59
3692.HK
+0.20
4.51%